Now approved
For acute and maintenance treatment of schizophrenia
Rethink the way you treat

New Once-Monthly Invega Sustenna

Brand name: Invega Sustenna
Generic name/category: paliperidone palmitate, atypical antipsychotic
Company: Janssen
Country/Market: USA, North America
Indication(s)/use: acute and maintenance treatment of schizophrenia in adults
Target: Healthcare Professionals (HCP)
Tagline: Rethink the way you treat
Medium: Print ad
Size/duration: Double-page spread
Publication/Aired: Psychiatric Services – November 2009

To see all of this brand's ads on AdPharm, click here

Click here to see the details and full-size version of this ad on AdPharm

AdPharm is the largest online pharmaceutical advertising gallery. It is subscription-based with various subscriptions plans available here.

[Visual]
A family of four eats at a diner. While they are enjoying their meal, a robot-like creature comes out of the mouth of the youngest of the children. Mechanical sounds and a siren can be heard. Attached to the creature is a red phone which starts ringing. The parents answer it.

[Creature]
Je suis une carie. Je viens attaquer une dent de votre fille et elle va avoir mal.
I am a tooth cavity. I am here to attack the tooth of your daughter and she’ll feel pain.

[Visual]
The communication is lost and the creature gets back into the little girl’s mouth.

[Voice-over and Super]
Ne rêvez pas, les problèmes dentaires ne préviennent pas. L’assurance maladie offre aux 6-18 ans des rendez-vous de prévention chez le dentiste.
Don’t dream, dental problems do not warn you before they happen. Health insurance offers 6-18 year-old’s prevention check-ups at the dentist.

www.mtdents.info

L’Assurance maladie

Agency: BDDP Unlimited

Brand name: Assurance Maladie
Generic name/category: Health services, prevention
Country/Market: France, Europe
Indication(s)/use: Tooth decay, cavity
Target: Consumers (DTC)
Medium: TV commercial
Size/duration: 30 seconds
Publication/Aired: 2009

Natural tears formula.
Don’t ask how.

Visine is a brand of eye drops produced by Johnson & Johnson. Johnson & Johnson acquired Visine, along with Pfizer’s entire consumer healthcare portfolio, in December 2006.

The active ingredients in the original Visine formulation are potassium chloride and tetrahydrozoline hydrochloride which is a vasoconstrictor, and therefore constricts the eye’s superficial blood vessels to “get the red out”, as claimed in Johnson & Johnson’s advertising

More on Wikipedia

Brand name: Visine
Generic name/category: tetrahydrozoline hydrochloride
Company: Johnson & Johnson Healthcare Products Division of McNEIL-PPC
Country/Market: USA
Indication(s)/use: Red eye
Target: Consumer DTC
Tagline: Natural tears formula. Don’t ask how.
Publication: 2008
Agency: JWT New York
Executive Creative Director: Andrew Clarke and Kash Sree
Creative Director: Raphael Milczarek
Copywriter: Humberto Jiron
Illustrator: Aaron Padin
Photographer: Hans Starck (Grosser Fotografen)